178 related articles for article (PubMed ID: 2556314)
21. Epidermal growth factor receptors in human breast carcinoma cells: a potential selective target for transforming growth factor alpha-Pseudomonas exotoxin 40 fusion protein.
Arteaga CL; Hurd SD; Dugger TC; Winnier AR; Robertson JB
Cancer Res; 1994 Sep; 54(17):4703-9. PubMed ID: 8062268
[TBL] [Abstract][Full Text] [Related]
22. Polyethylene glycol-modified chimeric toxin composed of transforming growth factor alpha and Pseudomonas exotoxin.
Wang QC; Pai LH; Debinski W; FitzGerald DJ; Pastan I
Cancer Res; 1993 Oct; 53(19):4588-94. PubMed ID: 8402632
[TBL] [Abstract][Full Text] [Related]
23. Properties of chimeric toxins with two recognition domains: interleukin 6 and transforming growth factor alpha at different locations in Pseudomonas exotoxin.
Kreitman RJ; Siegall CB; Chaudhary VK; FitzGerald DJ; Pastan I
Bioconjug Chem; 1992; 3(1):63-8. PubMed ID: 1616951
[TBL] [Abstract][Full Text] [Related]
24. Increased cytotoxicity of interleukin 2-pseudomonas exotoxin (IL2-PE) chimeric proteins containing a targeting signal for lysosomal membranes.
Fishman A; Bar-Kana Y; Steinberger I; Lorberboum-Galski H
Biochemistry; 1994 May; 33(20):6235-43. PubMed ID: 8193138
[TBL] [Abstract][Full Text] [Related]
25. Replacement of N-terminal portions of TGF-alpha with corresponding heregulin sequences affects ligand-induced receptor signaling and intoxication of tumor cells by chimeric growth-factor toxins.
Schmidt M; Wels W
Int J Cancer; 2002 Jan; 97(3):349-56. PubMed ID: 11774287
[TBL] [Abstract][Full Text] [Related]
26. TGF alpha-PE40 inhibits non-small cell lung cancer growth.
Draoui M; Siegall CB; FitzGerald D; Pastan I; Moody TW
Life Sci; 1994; 54(7):445-53. PubMed ID: 8309347
[TBL] [Abstract][Full Text] [Related]
27. Cytotoxicity of IL6-PE40 and derivatives on tumor cells expressing a range of interleukin 6 receptor levels.
Siegall CB; FitzGerald DJ; Pastan I
J Biol Chem; 1990 Sep; 265(27):16318-23. PubMed ID: 2118904
[TBL] [Abstract][Full Text] [Related]
28. Rational design of a chimeric toxin: an intramolecular location for the insertion of transforming growth factor alpha within Pseudomonas exotoxin as a targeting ligand.
Kreitman RJ; Chaudhary VK; Siegall CB; FitzGerald DJ; Pastan I
Bioconjug Chem; 1992; 3(1):58-62. PubMed ID: 1616950
[TBL] [Abstract][Full Text] [Related]
29. Single-chain immunotoxins directed at the human transferrin receptor containing Pseudomonas exotoxin A or diphtheria toxin: anti-TFR(Fv)-PE40 and DT388-anti-TFR(Fv).
Batra JK; Fitzgerald DJ; Chaudhary VK; Pastan I
Mol Cell Biol; 1991 Apr; 11(4):2200-5. PubMed ID: 2005905
[TBL] [Abstract][Full Text] [Related]
30. Small chimeric toxins containing only transforming growth factor alpha and domain III of Pseudomonas exotoxin with good antitumor activity in mice.
Kihara A; Pastan I
Cancer Res; 1994 Oct; 54(19):5154-9. PubMed ID: 7923133
[TBL] [Abstract][Full Text] [Related]
31. The effects of transferrin receptor antibody, transferrin receptor antibody bound to Pseudomonas exotoxin and transforming growth factor-alpha bound to Pseudomonas exotoxin on human tenon's capsule fibroblast proliferation.
Smyth RJ; Kitada S; Lee DA
J Ocul Pharmacol; 1992; 8(1):83-90. PubMed ID: 1402298
[TBL] [Abstract][Full Text] [Related]
32. Cell-specific toxicity of a chimeric protein composed of interleukin-6 and Pseudomonas exotoxin (IL6-PE40) on tumor cells.
Siegall CB; Nordan RP; FitzGerald DJ; Pastan I
Mol Cell Biol; 1990 Jun; 10(6):2443-7. PubMed ID: 2160579
[TBL] [Abstract][Full Text] [Related]
33. Pseudomonas Exotoxin A Based Toxins Targeting Epidermal Growth Factor Receptor for the Treatment of Prostate Cancer.
Fischer A; Wolf I; Fuchs H; Masilamani AP; Wolf P
Toxins (Basel); 2020 Nov; 12(12):. PubMed ID: 33260619
[TBL] [Abstract][Full Text] [Related]
34. A recombinant form of Pseudomonas exotoxin A containing transforming growth factor alpha near its carboxyl terminus for the treatment of bladder cancer.
Theuer CP; FitzGerald DJ; Pastan I
J Urol; 1993 Jun; 149(6):1626-32. PubMed ID: 8501821
[TBL] [Abstract][Full Text] [Related]
35. Cytotoxic activity of an interleukin 6-Pseudomonas exotoxin fusion protein on human myeloma cells.
Siegall CB; Chaudhary VK; FitzGerald DJ; Pastan I
Proc Natl Acad Sci U S A; 1988 Dec; 85(24):9738-42. PubMed ID: 3264406
[TBL] [Abstract][Full Text] [Related]
36. Activity of immunotoxins constructed with modified Pseudomonas exotoxin A lacking the cell recognition domain.
Kondo T; FitzGerald D; Chaudhary VK; Adhya S; Pastan I
J Biol Chem; 1988 Jul; 263(19):9470-5. PubMed ID: 3132465
[TBL] [Abstract][Full Text] [Related]
37. The heparin-binding domain of heparin-binding EGF-like growth factor can target Pseudomonas exotoxin to kill cells exclusively through heparan sulfate proteoglycans.
Mesri EA; Ono M; Kreitman RJ; Klagsbrun M; Pastan I
J Cell Sci; 1994 Sep; 107 ( Pt 9)():2599-608. PubMed ID: 7844173
[TBL] [Abstract][Full Text] [Related]
38. Targeted inhibition of tumor-cell growth by recombinant heregulin-toxin fusion proteins.
Jeschke M; Wels W; Dengler W; Imber R; Stöcklin E; Groner B
Int J Cancer; 1995 Mar; 60(5):730-9. PubMed ID: 7860149
[TBL] [Abstract][Full Text] [Related]
39. Construction and functional characterization of scFv(14E1)-ETA - a novel, highly potent antibody-toxin specific for the EGF receptor.
Schmidt M; Vakalopoulou E; Schneider DW; Wels W
Br J Cancer; 1997; 75(11):1575-84. PubMed ID: 9184171
[TBL] [Abstract][Full Text] [Related]
40. Selective toxicity of TGF-alpha-PE40 to EGFR-positive cell lines: selective protection of low EGFR-expressing cell lines by EGF.
Kirk J; Carmichael J; Stratford IJ; Harris AL
Br J Cancer; 1994 Jun; 69(6):988-94. PubMed ID: 8198991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
